{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Musculoskeletal+Cancer", "query": { "condition": "Musculoskeletal Cancer" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 612, "total_pages": 62, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Musculoskeletal+Cancer&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T05:56:20.166Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00726128", "title": "Patient Outcomes Evaluation of the EBI Vuelock™ Anterior Cervical Plate System", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Trauma", "Tumor", "Pseudarthrosis", "Scoliosis", "Degenerative Disc Disease" ], "interventions": [ { "name": "VueLock™ Anterior Cervical Plate", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Zimmer Biomet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 371, "start_date": "1998-08", "completion_date": "2009-09", "has_results": false, "last_update_posted_date": "2020-02-24", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 4, "location_summary": "Palo Alto, California • San Diego, California • Avon, Indiana + 1 more", "locations": [ { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Avon", "state": "Indiana" }, { "city": "Raleigh", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00726128" }, { "nct_id": "NCT03420963", "title": "Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Recurrent Cutaneous Melanoma", "Recurrent Lip and Oral Cavity Carcinoma", "Recurrent Malignant Endocrine Neoplasm", "Recurrent Malignant Female Reproductive System Neoplasm", "Recurrent Malignant Male Reproductive System Neoplasm", "Recurrent Malignant Mesothelioma", "Recurrent Malignant Neoplasm of Multiple Primary Sites", "Recurrent Malignant Oral Neoplasm", "Recurrent Malignant Pharyngeal Neoplasm", "Recurrent Malignant Skin Neoplasm", "Recurrent Malignant Soft Tissue Neoplasm", "Recurrent Malignant Solid Neoplasm", "Recurrent Malignant Thyroid Gland Neoplasm", "Recurrent Malignant Urinary System Neoplasm", "Refractory Cutaneous Melanoma", "Refractory Malignant Bone Neoplasm", "Refractory Malignant Endocrine Neoplasm", "Refractory Malignant Female Reproductive System Neoplasm", "Refractory Malignant Male Reproductive System Neoplasm", "Refractory Malignant Mesothelioma", "Refractory Malignant Neoplasm of Multiple Primary Sites", "Refractory Malignant Oral Neoplasm", "Refractory Malignant Pharyngeal Neoplasm", "Refractory Malignant Skin Neoplasm", "Refractory Malignant Soft Tissue Neoplasm", "Refractory Malignant Solid Neoplasm", "Refractory Malignant Thyroid Gland Neoplasm", "Refractory Malignant Urinary System Neoplasm" ], "interventions": [ { "name": "Cord Blood-derived Expanded Allogeneic Natural Killer Cells", "type": "BIOLOGICAL" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "40 Years", "sex": "ALL", "summary": "12 Months to 40 Years" }, "enrollment_count": 12, "start_date": "2018-08-31", "completion_date": "2026-02-26", "has_results": false, "last_update_posted_date": "2026-03-20", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03420963" }, { "nct_id": "NCT04958434", "title": "Study of TST005 in Patients With Locally Advanced or Metastatic Solid Tumors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Locally Advanced or Metastatic Cancers", "Metastatic Human Papillomavirus-Related Malignant Neoplasm" ], "interventions": [ { "name": "TST005", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Suzhou Transcenta Therapeutics Co., Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 19, "start_date": "2021-06-11", "completion_date": "2023-09-30", "has_results": false, "last_update_posted_date": "2023-10-23", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 3, "location_summary": "Canton, Ohio • Dallas, Texas • San Antonio, Texas", "locations": [ { "city": "Canton", "state": "Ohio" }, { "city": "Dallas", "state": "Texas" }, { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04958434" }, { "nct_id": "NCT07325578", "title": "U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bone Tumor", "Osteoporosis", "Traumatic Fracture" ], "interventions": [ { "name": "Percutaneous procedure in the MSK structures of the pelvis and/or the spine", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Precision IO Group", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 60, "start_date": "2026-04-28", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-07-20", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 3, "location_summary": "San Diego, California • Miami, Florida • Chicago, Illinois", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07325578" }, { "nct_id": "NCT05417789", "title": "Study of Emactuzumab for Tenosynovial Giant Cell Tumor (TGCT)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "TGCT" ], "interventions": [ { "name": "Emactuzumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SynOx Therapeutics Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 128, "start_date": "2024-10-09", "completion_date": "2027-09-30", "has_results": false, "last_update_posted_date": "2026-02-02", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 10, "location_summary": "Beverly Hills, California • Los Angeles, California • Overland Park, Kansas + 6 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Overland Park", "state": "Kansas" }, { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05417789" }, { "nct_id": "NCT07552558", "title": "Ficerafusp Alfa, Pembrolizumab, and Stereotactic Body Radiotherapy (SBRT) for Head and Neck Squamous Cell Carcinoma (HNSCC)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Head and Neck Squamous Cell Carcinoma", "HPV-Negative Squamous Cell Carcinoma" ], "interventions": [ { "name": "Hypofractionated Stereotactic Body Radiotherapy (SBRT)", "type": "RADIATION" }, { "name": "Pembrolizumab", "type": "BIOLOGICAL" }, { "name": "Ficerafusp alfa", "type": "DRUG" } ], "intervention_types": [ "RADIATION", "BIOLOGICAL", "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 45, "start_date": "2026-06-30", "completion_date": "2033-08-31", "has_results": false, "last_update_posted_date": "2026-06-03", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07552558" }, { "nct_id": "NCT04122313", "title": "Post-contracture Release Radiation for Dupuytren's Disease", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Dupuytren's Disease", "Dupuytren Contracture", "Dupuytren Disease of Palm and Finger", "Dupuytren Disease of Finger", "Dupuytrens Contracture of Both Hands", "Dupuytren's Disease of Palm of Right Hand", "Dupuytren's Disease of Palm of Left Hand", "Dupuytren Contracture of Right Palm", "Dupuytren Contracture of Left Palm", "Dupuytren's Contracture Left", "Dupuytren's Contracture Right" ], "interventions": [ { "name": "Evaluation of Dupuytren's Disease Treatment", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2019-05-31", "completion_date": "2029-03-01", "has_results": false, "last_update_posted_date": "2026-03-19", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04122313" }, { "nct_id": "NCT02192333", "title": "Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Breast Carcinoma", "Cancer Survivor", "Depression", "Fatigue", "Leukemia", "Lymphoma", "Malignant Bone Neoplasm", "Malignant Digestive System Neoplasm", "Malignant Female Reproductive System Neoplasm", "Malignant Male Reproductive System Neoplasm", "Pain", "Sleep Disorder", "Soft Tissue Sarcoma" ], "interventions": [ { "name": "Management of Therapy Complications", "type": "PROCEDURE" }, { "name": "Quality-of-Life Assessment", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Telephone-Based Intervention", "type": "BEHAVIORAL" } ], "intervention_types": [ "PROCEDURE", "OTHER", "BEHAVIORAL" ], "sponsor": "Fred Hutchinson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "39 Years", "sex": "ALL", "summary": "18 Years to 39 Years" }, "enrollment_count": 390, "start_date": "2015-08-03", "completion_date": "2019-12-31", "has_results": false, "last_update_posted_date": "2020-10-09", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 6, "location_summary": "Los Angeles, California • Aurora, Colorado • Boston, Massachusetts + 3 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Chapel Hill", "state": "North Carolina" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02192333" }, { "nct_id": "NCT00444535", "title": "Lapatinib and Bevacizumab for Metastatic Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neoplasms, Breast" ], "interventions": [ { "name": "lapatinib", "type": "DRUG" }, { "name": "bevacizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 52, "start_date": "2007-02-27", "completion_date": "2020-06-19", "has_results": true, "last_update_posted_date": "2021-10-25", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 9, "location_summary": "Tucson, Arizona • San Francisco, California • Hollywood, Florida + 6 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "San Francisco", "state": "California" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Basking Ridge", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00444535" }, { "nct_id": "NCT00427804", "title": "Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rheumatoid Arthritis", "Crohn's Disease" ], "interventions": [ { "name": "calcitriol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Atlanta VA Medical Center", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "MALE", "summary": "18 Years to 50 Years · Male only" }, "enrollment_count": 9, "start_date": "2007-01", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2013-02-04", "last_synced_at": "2026-07-22T05:56:20.166Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00427804" } ] }